Table 2. Seroconversion rates following varying doses of purified inactivated EV71.
Day 28 | Day 56 | ||
Group | Dose | % seroconverted (n) | % seroconverted (n) |
1 | Alum control | 0 (0/10) | 0 (0/10) |
2 | 0.12 µg EV71+Alum | 10 (1/10) | 50 (5/10) |
3 | 0.6 µg EV71+Alum | 20 (2/10) | 90 (9/10) |
4 | 3 µg EV71+Alum | 70 (7/10) | 100 (10/10) |
5 | 9 µg EV71+Alum | 40 (4/10) | 100 (10/10) |
6 | 15 µg EV71+Alum | 80 (8/10) | 100 (10/10) |
BALB/c mice were immunized with purified inactivated EV71 virus with Alhydrogel, at 28 days and 56 days post primary immunization. Seroconversion is defined as a neutralizing antibody titre of ≥128.